Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Rheumatology (Oxford, England)|November 26, 2009
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyDavid Isenberg, Gerald B Appel, Gabriel Contreras, et al.
Kidney International Reports|May 2, 2022
Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus NephritisElisabeth M J Bos, Shirish R Sangle, Suzanne Wilhelmus, et al.
Rheumatology (Oxford, England)|February 11, 2010
Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritisTamar Rubinstein, Milena Pitashny, Benjamin Levine, et al.
The New England Journal of Medicine|November 18, 2011
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritisMary Anne Dooley, David Jayne, Ellen M Ginzler, et al.
Scientific Reports|September 9, 2017
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid SyndromeBahar Artim-Esen, Natalia Smoktunowicz, Thomas McDonnell, et al.
The Journal of Rheumatology|August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis SymptomsLisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Journal of the American Society of Nephrology : JASN|April 17, 2009
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritisGerald B Appel, Gabriel Contreras, Mary Anne Dooley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actionsIan Giles, Charis Pericleous, Xiaowei Liu, et al.
Pageof 16